{"id":4963,"date":"2023-08-17T08:24:57","date_gmt":"2023-08-17T08:24:57","guid":{"rendered":"https:\/\/innovationisrael.org.il\/en\/?page_id=4963"},"modified":"2023-08-20T11:50:26","modified_gmt":"2023-08-20T11:50:26","slug":"international-health-tech-rd-and-pilot-program","status":"publish","type":"page","link":"https:\/\/innovationisrael.org.il\/en\/international-health-tech-rd-and-pilot-program\/","title":{"rendered":"International Health-Tech R&D and Pilot Program"},"content":{"rendered":"\n
<\/p>\n\n\n\n
Open Date<\/strong>: September 19th, 2022<\/mark><\/strong><\/p>\n\n\n\n Deadline for Submission of Expressions of Interest (EOIs)<\/strong>: November 14, 2022<\/mark><\/strong> The Israel Innovation Authority, together with HealthIL, the Healthcare Innovation Ecosystem in Israel, and selected international health centers jointly open the International Health-Tech Partnership Program. Interested Israeli companies are invited to submit applications to co-develop, pilot, test, adapt and optimize impactful healthcare-related technologies, services, and devices in a clinical environment at leading global hospitals (listed in alphabetic order):<\/p>\n\n\n\n <\/p>\n\n\n\n The goals of the collaboration are to stimulate transnational partnerships, accelerate the availability of medical innovations to the public, introduce Israeli healthcare technology to global markets, and advance the development of discoveries for the benefit of patients all over the world.<\/p>\n\n\n\n Please see the full details in the following Program Guidelines (listed in alphabetic order): Healthcare-related technologies, services, and devices. Each hospital has unique interest areas, listed in the program guidelines.<\/p>\n\n\n\n
<\/p>\n\n\n\nProgram Description<\/h4>\n\n\n\n
\n
Successful applicant companies will receive funding from the Israel Innovation Authority, in addition to support from the partnering hospital.<\/p>\n\n\n\n
\u2022Charit\u00e9 – Universit\u00e4tsmedizin Berlin \u2013 Program Guidelines<\/a>
\u2022HHC \u2013 Program Guidelines<\/a>
\u2022Mayo Clinic \u2013 Program Guidelines<\/a>
\u2022Northern Health Science Alliance (NHSA) – Program Guidelines<\/a>
\u2022Thomas Jefferson \u2013 Program Guidelines<\/a><\/p>\n\n\n\nRelevant Technologies<\/h4>\n\n\n\n
Conditions and Criteria<\/h4>\n\n\n\n
\n
There are two possible collaboration tracks:<\/h4>\n\n\n\n
\n
\n
Examples for recognized expenses: The Israeli Company’s activity required to complete the project, such as renting equipment, personnel, and subcontractors, adapting a product for marketing, registering patents, and air travel.
Example for unrecognized expenses: Fees for IRB approval, health organization overheads, administrative, office, accounting, and legal expenses.<\/p>\n\n\n\n